Rogé, M.; Salleron, J.; Kirova, Y.; Guigo, M.; Cailleteau, A.; Levy, C.; Leheurteur, M.; Nebbache, R.; Rivin Del Campo, E.; Lazarescu, I.;
et al. Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study. Cancers 2022, 14, 3928.
https://doi.org/10.3390/cancers14163928
AMA Style
Rogé M, Salleron J, Kirova Y, Guigo M, Cailleteau A, Levy C, Leheurteur M, Nebbache R, Rivin Del Campo E, Lazarescu I,
et al. Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study. Cancers. 2022; 14(16):3928.
https://doi.org/10.3390/cancers14163928
Chicago/Turabian Style
Rogé, Maximilien, Julia Salleron, Youlia Kirova, Marin Guigo, Axel Cailleteau, Christelle Levy, Marianne Leheurteur, Rafik Nebbache, Eleonor Rivin Del Campo, Ioana Lazarescu,
and et al. 2022. "Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study" Cancers 14, no. 16: 3928.
https://doi.org/10.3390/cancers14163928
APA Style
Rogé, M., Salleron, J., Kirova, Y., Guigo, M., Cailleteau, A., Levy, C., Leheurteur, M., Nebbache, R., Rivin Del Campo, E., Lazarescu, I., Servagi, S., Aumont, M., Thariat, J., & Thureau, S.
(2022). Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study. Cancers, 14(16), 3928.
https://doi.org/10.3390/cancers14163928
